Procter & Gamble is lining up its next health care boss, and it is sticking with a familiar face. The Cincinnati-based consumer powerhouse has tapped Paul Gama to lead its Health Care business as longtime executive Jennifer Davis heads toward retirement after more than 33 years with the company. Davis is expected to step down on June 30, 2026, handing over a division that generated roughly $12 billion in net sales in the last fiscal year. The move keeps succession in-house at P&G, where leadership continuity is something investors and retailers tend to watch closely.
According to Procter & Gamble, Gama is listed as Chief Executive Officer, Health Care and will oversee the company’s oral- and personal-health brands. The company notes he is in the role for 2026 and highlights that he previously ran P&G's Personal Health Care business before stepping into the broader health care post.
Jennifer Davis' planned exit surfaced in a Form 8-K P&G filed in December, which shows she notified the company on December 9, 2025, of her intent to retire effective June 30, 2026, according to the SEC. As reported by the Cincinnati Business Courier, her departure and Gama's elevation put him in charge of a core unit of P&G's consumer-health strategy.
Who Is Paul Gama?
Gama has been leading P&G’s Personal Health Care organization and brings decades of industry experience, including senior roles at Bayer, Novartis and Reckitt. The Consumer Healthcare Products Association has highlighted his work on well-known brands and his past leadership of the trade group, underscoring his profile in the over-the-counter space.
Health Care at a Glance
P&G's Health Care segment reported roughly $12.0 billion in net sales in the most recent fiscal year, according to the company's filings with the SEC. The unit spans oral care and personal-health categories that include some of P&G's largest global brands and remains a meaningful contributor to the company’s overall revenue mix.
What Cincinnati Will Watch
In Cincinnati and on Wall Street, attention will turn to how Gama steers the health care ship once the handoff is complete. Analysts and local observers will be watching his approach to innovation, pricing and partnerships across over-the-counter and oral-care brands as competition heats up in consumer health. The transition, reported by the Cincinnati Business Courier, underscores P&G’s preference for promoting from within and gives the Queen City another senior executive to track as the company navigates a crowded market.
